Literature DB >> 9195549

Pleural sclerosis for the treatment of pneumothorax and pleural effusion.

R W Light1, F S Vargas.   

Abstract

Pleural sclerosis is indicated to obliterate the pleural space when one wants to prevent the recurrence of a spontaneous pneumothorax or the reaccumulation of a pleural effusion. Although many different agents ranging from antibiotics to antiseptics to antineoplastics to talc have been advocated, none is ideal. It is interesting that in the era when we are mapping the human genome, the agent most commonly used for pleurodesis is talc. Talc is very inhomogeneous, and the mechanisms by which it produces pleurodesis are unknown. In this review we will discuss the theory and mechanism of pleurodesis, the indications and contraindications for it, the advantages and disadvantages of the agents presently used for it, and our recommendations for the procedure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9195549     DOI: 10.1007/pl00007568

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  11 in total

1.  Intrapleural administration of a large amount of diluted fibrin glue for intractable pneumothorax. A clinical study based on 57 cases: including 2 unsuccessful cases.

Authors:  Takahiro Kinoshita; Shinichiro Miyoshi; Takaomi Suzuma; Teruhisa Sakurai; Katsumi Enomoto; Tatsuya Yoshimasu; Shinzi Maebeya; Masanobu Juri; Yoshitaka Okamura
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-02

2.  Efficacy of posterior fixation suture augmented with talc or doxycycline.

Authors:  Yeon-Hee Lee; Kwang-Sun Suh; Jeong-Min Hwang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-04-21       Impact factor: 3.117

3.  Polidocanol at different concentrations for pleurodesis in rats.

Authors:  Bahadir Cetin; E Arzu Koçkaya; Can Atalay; M Turan Akay
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

4.  Production of experimental malignant pleural effusions is dependent on invasion of the pleura and expression of vascular endothelial growth factor/vascular permeability factor by human lung cancer cells.

Authors:  S Yano; H Shinohara; R S Herbst; H Kuniyasu; C D Bucana; L M Ellis; I J Fidler
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

5.  Transforming growth factor beta(2) (TGF beta(2)) produces effective pleurodesis in sheep with no systemic complications.

Authors:  Y C Lee; K B Lane; R E Parker; D S Ayo; J T Rogers; R W Diters; P J Thompson; R W Light
Journal:  Thorax       Date:  2000-12       Impact factor: 9.139

6.  Moxifloxacin pharmacokinetics and pleural fluid penetration in patients with pleural effusion.

Authors:  Kalliopi Chatzika; Katerina Manika; Paschalina Kontou; Georgia Pitsiou; Despina Papakosta; Konstantinos Zarogoulidis; Ioannis Kioumis
Journal:  Antimicrob Agents Chemother       Date:  2013-12-09       Impact factor: 5.191

7.  Comparison of additional minocycline versus iodopovidone pleurodesis during video-assisted thoracoscopic bleb resection for primary spontaneous pneumothorax: a propensity score-matched analysis.

Authors:  Kang Hoon Lee; Bo Taek Kim; Hyun Koo Kim; Kook Nam Han; Young Ho Choi
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

8.  Blood-patch pleurodesis for pneumothorax in lung fibrosis due to progressive systemic sclerosis: A case report.

Authors:  Katsunori Kagohashi; Gen Ohara; Toshihiro Shiozawa; Tomohiro Tamura; Kunihiko Miyazaki; Koichi Kurishima; Hiroaki Satoh; Nobuyuki Hizawa
Journal:  Exp Ther Med       Date:  2014-09-29       Impact factor: 2.447

9.  Pleurodesis induction in rats by Copaiba (Copaifera multijuga Hayne) oil.

Authors:  Fernando Luiz Westphal; Mauro Canzian; Fabio Alessandro Pieri; Alfredo Coimbra Reichl; Paulo Manuel Pêgo-Fernandes; Luis Carlos Lima; Valdir F Veiga-Junior
Journal:  Biomed Res Int       Date:  2014-06-09       Impact factor: 3.411

10.  Chest ultrasonography to assess the kinetics and efficacy of talc pleurodesis in a model of pneumothorax: an experimental animal study.

Authors:  Rachid Tazi-Mezalek; Diane Frankel; Marc Fortin; Elise Kaspi; Julien Guinde; Alexandra Assolen; Sophie Laroumagne; Andree Robaglia; Herve Dutau; Patrice Roll; Philippe Astoul
Journal:  ERJ Open Res       Date:  2018-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.